Funding Rounds
F2G

F2G Unknown (2022, $70M)

F2G

Oral antifungal therapy developer to treat life-threatening rare fungal infections

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $70.00M

Raised Date: 2022-01-01

Investors